Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China. [electronic resource]
Publication details: Archives of medical science : AMS May 2019Description: 700-705 p. digitalISSN:- 1734-1922
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.